Pilocarpine 1% Ophth Soln 15ml
Overview
What is this medicine?
How to Use This Medicine
To use this medication correctly, follow your doctor's instructions and read all the information provided. This medication is for use in the eyes only.
Preparation and Administration
1. Wash your hands before and after using this medication.
2. Remove contact lenses before applying the medication. You can put them back in 10 minutes after use, but avoid doing so if your eyes are irritated or infected.
3. Avoid touching the container tip to your eye, lid, or other skin, as this can introduce bacteria and lead to severe eye problems or vision loss.
4. Tilt your head back and gently drop the medication into your eye.
5. After application, keep your eyes closed and apply pressure to the inside corner of your eye for 1 to 2 minutes to help the medication stay in your eye.
Using Multiple Medications
If you are using more than one medication in the same eye, apply each medication at least 5 minutes apart.
Storage and Disposal
1. Store this medication at room temperature, away from freezing temperatures.
2. Keep all medications in a safe place, out of the reach of children and pets.
3. Dispose of unused or expired medications properly. Do not flush them down the toilet or pour them down the drain unless instructed to do so. Consult your pharmacist for guidance on disposal, and consider participating in a drug take-back program in your area.
Missed Dose
If you miss a dose, use it as soon as you remember. However, if it is close to the time for your next dose, skip the missed dose and resume your regular schedule. Do not use two doses at the same time or take extra doses.
Lifestyle & Tips
- Do not drive or operate machinery if you experience blurred vision or difficulty with night vision after using these drops.
- Avoid activities requiring sharp vision in dim light, especially at night.
- If you wear contact lenses, remove them before applying the drops and wait at least 15 minutes before reinserting them.
- Wash hands thoroughly before and after use.
- Do not touch the dropper tip to any surface to prevent contamination.
- If using other eye drops, wait at least 5-10 minutes between applications.
Available Forms & Alternatives
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
Side Effects
Although rare, this medication can cause severe and potentially life-threatening side effects. If you experience any of the following symptoms, contact your doctor or seek medical attention immediately:
Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Changes in eyesight, eye pain, or severe eye irritation
Severe eye problems, including:
+ Retinal tear or detachment (especially in people with pre-existing retinal disease)
+ Sudden symptoms such as:
- Flashing lights
- Floaters
- A curtain-like shadow coming across your eye
- Sudden eyesight loss
Other Possible Side Effects
Like all medications, this drug can cause side effects. While many people may not experience any side effects or only minor ones, it's essential to discuss any concerns with your doctor. If you experience any of the following side effects, or if they bother you or do not go away, contact your doctor:
Headache
Eye irritation
Blurred eyesight
Eye redness
Temporary dim or dark eyesight
Reporting Side Effects
This list is not exhaustive, and you may experience other side effects. If you have questions or concerns, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Severe eye pain or sudden vision changes
- Signs of allergic reaction (e.g., rash, itching, swelling of face/tongue/throat, severe dizziness, trouble breathing)
- Persistent or worsening brow ache/headache
- Significant increase in eye redness or irritation
- Systemic symptoms like excessive sweating, nausea, vomiting, diarrhea, slow heart rate, or difficulty breathing (though rare with ophthalmic use, seek immediate medical attention if they occur).
Before Using This Medicine
It is essential to inform your doctor about the following:
Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the allergic reaction you experienced, including any symptoms that occurred.
If you have a specific eye condition called iritis.
This list is not exhaustive, and it is crucial to discuss all your medications (including prescription, over-the-counter, natural products, and vitamins) and health issues with your doctor and pharmacist. They will help determine if it is safe to take this medication in conjunction with your other medications and health conditions.
Remember, do not start, stop, or modify the dosage of any medication without first consulting your doctor to ensure your safety.
Precautions & Cautions
Overdose Information
Overdose Symptoms:
- Excessive sweating
- Nausea
- Vomiting
- Diarrhea
- Abdominal cramps
- Bradycardia (slow heart rate)
- Hypotension (low blood pressure)
- Bronchospasm (difficulty breathing)
- Increased salivation and lacrimation (tearing)
- Muscle tremors or weakness
What to Do:
If swallowed or excessive systemic absorption occurs, seek immediate medical attention or call a poison control center (e.g., 1-800-222-1222). Treatment is supportive and may involve atropine as an antidote for muscarinic effects.
Drug Interactions
Moderate Interactions
- Anticholinergic agents (e.g., atropine, scopolamine, tricyclic antidepressants, antihistamines): May antagonize the miotic and IOP-lowering effects of pilocarpine.
- Beta-blockers (ophthalmic or systemic): May potentiate bradycardia or bronchospasm if significant systemic absorption occurs, though rare with ophthalmic pilocarpine.
Monitoring
Baseline Monitoring
Rationale: To establish baseline and assess efficacy of treatment.
Timing: Before initiating therapy
Rationale: To assess baseline vision and monitor for changes.
Timing: Before initiating therapy
Rationale: To assess baseline glaucoma damage and monitor progression.
Timing: Before initiating therapy
Routine Monitoring
Frequency: Regularly, as determined by ophthalmologist (e.g., every 3-6 months or more frequently if unstable)
Target: Individualized target IOP set by ophthalmologist
Action Threshold: IOP above target range, or significant fluctuation
Frequency: Annually or as clinically indicated
Target: Stable or improved
Action Threshold: Significant decrease in vision
Frequency: Annually or as clinically indicated (e.g., every 6-12 months)
Target: Stable or improved
Action Threshold: Progression of glaucoma damage
Frequency: At each follow-up visit and patient self-reporting
Target: Minimal to tolerable
Action Threshold: Severe or intolerable side effects impacting quality of life
Symptom Monitoring
- Blurred vision (especially at night or in dim light)
- Brow ache or headache (especially upon initiation)
- Stinging or burning sensation in the eye
- Redness or irritation of the eye
- Increased tearing
- Difficulty with night vision
- Systemic symptoms (rare): sweating, nausea, vomiting, diarrhea, abdominal cramps, muscle tremors, bradycardia, bronchospasm (report immediately if severe)
Special Patient Groups
Pregnancy
Pilocarpine ophthalmic is classified as Pregnancy Category C. It should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Systemic absorption from ophthalmic administration is generally minimal, but animal studies have shown some adverse effects at high doses.
Trimester-Specific Risks:
Lactation
It is not known whether pilocarpine is excreted in human milk. Due to the potential for serious adverse reactions in nursing infants from pilocarpine, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother. Minimal systemic absorption suggests low risk, but caution is advised.
Pediatric Use
Safety and effectiveness in pediatric patients have not been established. Use in children is generally not recommended for routine glaucoma management; alternative treatments are often preferred. If used, it should be under strict specialist supervision due to potential for systemic side effects and impact on developing vision.
Geriatric Use
No specific dosage adjustments are typically required for elderly patients. However, elderly patients may be more susceptible to systemic side effects if significant absorption occurs, and they may experience more pronounced visual disturbances (e.g., dim vision, difficulty with night vision) due to age-related changes in the eye. Use with caution and monitor for adverse effects.
Clinical Information
Clinical Pearls
- Pilocarpine is a classic miotic agent, effective for lowering IOP but often associated with visual side effects (miosis, accommodative spasm, brow ache) that can impact patient compliance.
- The 1% concentration is a common starting point, but higher concentrations (e.g., 2%, 4%) are available for greater IOP reduction, though with increased side effects.
- Educate patients about potential blurred vision and difficulty with night vision, especially when starting therapy.
- Brow ache and headache are common initial side effects due to ciliary muscle spasm; they often diminish with continued use.
- Pilocarpine is particularly useful in acute angle-closure glaucoma to break the attack by pulling the iris away from the angle.
- Ensure proper instillation technique to minimize systemic absorption and maximize local effect (e.g., nasolacrimal occlusion).
Alternative Therapies
- Prostaglandin analogs (e.g., latanoprost, travoprost, bimatoprost)
- Beta-blockers (e.g., timolol, betaxolol)
- Alpha-2 adrenergic agonists (e.g., brimonidine, apraclonidine)
- Carbonic anhydrase inhibitors (e.g., dorzolamide, brinzolamide, acetazolamide)
- Rho kinase inhibitors (e.g., netarsudil)
- Combination products (e.g., timolol/dorzolamide, timolol/brimonidine)